(Reuters) - Johnson & Johnson is voluntarily recalling about 32 million packages of its birth control pill Cilest (ethinylestradiol and norgestimate) in Europe, Asia and Latin America, a spokeswoman said late on Tuesday, the latest in a string of recalls over the past two years. Cilest is manufactured by Janssen Pharmaceuticals Inc, a unit of Johnson & Johnson. Spokeswoman Michelle Romano said the recall of 179 batches was initiated because one active ingredient in Cilest did not lead to a "defined specification" in one routine internal test. Media reports have said the tests showed one of the two hormones in Cilest was being released more slowly than intended. The pill is available in 43 countries, but not in the U.S. The product remains safe and effective, Romano said, adding that there is no risk for the women who had taken the pill. Less than 800,000 individual consumer packets remain available for sale, she said.
Posted on: Sat, 08 Jun 2013 23:15:41 +0000
Trending Topics
Recently Viewed Topics
© 2015